ACTH Sex- and Cycle-Related Differences: Normal Range, Optimal Values, and Clinical Interpretation

What ACTH Actually Measures and Why It Matters

ACTH (adrenocorticotropic hormone) is a 39-amino-acid peptide released from the anterior pituitary that drives cortisol synthesis in the adrenal cortex. Its plasma concentration tells you where the problem is when the HPA (hypothalamic-pituitary-adrenal) axis misfires. A single fasting, morning ACTH result, read alongside a simultaneous serum cortisol, can locate pathology to the adrenal gland itself, the pituitary, or the hypothalamus.

The test is also increasingly used in functional and longevity medicine to detect subclinical HPA dysregulation long before overt adrenal insufficiency appears. That application requires tighter reference intervals than most hospital labs publish.

How ACTH Stimulates the Adrenal Cortex

ACTH binds the melanocortin-2 receptor (MC2R) on adrenocortical cells, activating a cAMP-mediated pathway that increases cholesterol transport into the mitochondria via StAR protein. Cortisol synthesis follows within minutes. Because cortisol feeds back negatively on both the pituitary and hypothalamus, basal ACTH reflects the net set-point of the entire axis. Chronic psychological stress or sleep disruption can reset that set-point upward, producing persistently elevated ACTH even when end-organ cortisol appears normal [1].

Why Specimen Handling Changes Everything

ACTH degrades rapidly in whole blood. Studies measuring ACTH in samples held at room temperature for 30 minutes found a mean loss of 18% [2]. Every clinical decision in this article assumes the sample was drawn into chilled EDTA tubes, placed immediately on crushed ice, and centrifuged within 15 minutes of collection. Failing that protocol, a "low" ACTH result may simply be a degraded one.

Standard Reference Ranges and Where They Come From

Most U.S. Laboratory reference intervals for ACTH trace back to manufacturer-derived populations and are not stratified by sex, cycle phase, or age with the granularity telehealth providers need. The published morning reference interval of 7.2 to 63 pg/mL originates from studies of fasting adults drawn between 6 and 9 AM [3]. That range captures roughly the central 95th percentile of a mixed-sex, mixed-age population.

Adult Morning Reference Interval

| Population | Reference interval (pg/mL) | Optimal functional target (pg/mL) | |---|---|---| | Men, ages 18 to 65 | 7.2 to 63 | 10 to 46 | | Premenopausal women, early follicular | 7.2 to 63 | 10 to 42 | | Premenopausal women, mid-cycle | 12 to 72 (cycle-adjusted) | 10 to 50 | | Postmenopausal women (not on HRT) | 7.2 to 56 | 10 to 40 | | Postmenopausal women (on oral estrogen) | May read 10 to 20% lower due to CBG changes | Interpret with cortisol ratio |

The "optimal functional target" column reflects longevity-medicine consensus rather than diagnostic cutoffs. A value between 10 and 46 pg/mL in a morning fasted draw suggests adequate HPA responsiveness without chronic hyperstimulation of the adrenal cortex.

What "Normal" Misses in Women

Standard lab ranges were derived predominantly from male subjects in many foundational endocrinology studies, a methodological gap the NIH Office of Research on Women's Health has formally documented [4]. A woman presenting with fatigue, cold intolerance, and a morning ACTH of 9 pg/mL might be flagged as "within range" when her clinical picture warrants further stimulation testing.

Sex-Based Differences in Basal ACTH

Men and women differ in HPA-axis activity at every level: hypothalamic CRH tone, pituitary corticotroph sensitivity, and adrenal cortisol output per unit ACTH. These differences are not subtle.

Higher Basal ACTH in Women

Cross-sectional population data from the Study of Women's Health Across the Nation (SWAN) and multiple smaller metabolic studies consistently show that premenopausal women have morning ACTH concentrations roughly 10 to 20% higher than age-matched men [5]. Estradiol appears to increase CRH receptor expression on pituitary corticotrophs, amplifying the pituitary response to hypothalamic drive. That effect is most pronounced when estradiol peaks near ovulation.

HPA Reactivity Differences Under Stress

Laboratory stressor paradigms (Trier Social Stress Test, TSST) reveal that women mount a larger ACTH response than men to psychosocial stress before age 50, while cortisol output per unit ACTH is actually similar or slightly lower. This means women's corticotroph cells fire more vigorously but the adrenal cortex may be somewhat less sensitive per ACTH molecule, an important nuance when ordering a cosyntropin stimulation test [6].

After menopause, the female advantage in peak ACTH reactivity attenuates, and sex differences in basal ACTH largely disappear within five to eight years of final menstrual period, unless exogenous hormone therapy is introduced.

Testosterone and ACTH in Men

Higher circulating testosterone in men appears to dampen HPA reactivity. Experimental androgen deprivation in prostate cancer patients increases both basal ACTH and cortisol awakening response within eight weeks [7]. Men on testosterone replacement therapy (TRT) at physiological doses (testosterone cypionate 100 to 200 mg/week to maintain total testosterone 500 to 900 ng/dL) generally show ACTH within the lower half of the reference range, around 12 to 35 pg/mL in clinical practice.

Menstrual-Cycle Phase Effects on ACTH

The menstrual cycle drives substantial within-woman variability in ACTH. Providers who draw ACTH without noting cycle day are comparing different physiological states to a single reference number. The framework below maps expected ACTH behavior across a 28-day cycle.

Early Follicular Phase (Days 1 to 7)

Estradiol is at its monthly nadir, progesterone is low, and ACTH concentrations track near the lower portion of the reference interval, typically 8 to 28 pg/mL in a woman without HPA pathology. This is the best window for baseline testing if the goal is ruling out secondary adrenal insufficiency, because the hormonal milieu most closely resembles the mixed-sex population from which reference ranges were derived.

Late Follicular and Ovulatory Phase (Days 8 to 14)

Rising estradiol increases pituitary corticotroph sensitivity. Studies using luteinizing hormone (LH) surge as a cycle anchor found ACTH concentrations 15 to 30% above early-follicular values in the 24 to 48 hours bracketing the LH surge [8]. A woman drawing a routine ACTH on day 12 of her cycle could show a result of 52 pg/mL that is physiologically normal for that phase yet reads as near the upper limit on her lab report.

Luteal Phase (Days 15 to 28)

Progesterone acts as a partial glucocorticoid-receptor agonist, which may reduce cortisol negative feedback, allowing ACTH to remain modestly elevated compared to the early follicular phase. The effect size is smaller than the peri-ovulatory rise, typically 5 to 15% above early-follicular values [8]. Women with premenstrual dysphoric disorder (PMDD) sometimes show exaggerated luteal-phase ACTH elevations, a finding that connects HPA dysregulation to mood symptomatology.

Practical Guidance: When to Draw ACTH in Women

For the cleanest baseline result, draw on cycle days 2 to 7 (early follicular), fasting, between 7 and 9 AM. If a woman is using hormonal contraception, note the formulation: combined oral contraceptives (COCs) raise corticosteroid-binding globulin (CBG), which increases total cortisol but does not affect free cortisol or ACTH itself. Progestin-only methods (e.g., norethindrone 0.35 mg/day, desogestrel 75 mcg/day) have minimal effect on ACTH.

ACTH in Pregnancy

Pregnancy is the most dramatic physiological context for ACTH elevation outside of pathology. Placental CRH, which is structurally identical to hypothalamic CRH, enters the maternal circulation in exponentially increasing amounts from week 16 onward.

Trimester-by-Trimester Changes

By the third trimester, maternal plasma ACTH may reach two to three times the non-pregnant morning reference interval, yet cortisol rises proportionally due to both increased adrenal output and CBG-mediated binding capacity increases [9]. Diagnosing adrenal insufficiency in pregnancy therefore requires simultaneous measurement of free or salivary cortisol, not total cortisol, alongside ACTH. The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency explicitly states that "standard cortisol reference ranges should not be applied in pregnancy without correction for the gestational rise in CBG" [10].

Postpartum HPA Normalization

After delivery, placental CRH disappears rapidly. Maternal ACTH concentrations typically return toward pre-pregnancy values within two to four weeks postpartum, but the HPA axis may remain transiently hypo-responsive for three to six months, contributing to postpartum fatigue and mood changes. A morning ACTH of 6 to 10 pg/mL in the first few months postpartum may therefore reflect transient secondary suppression rather than pituitary pathology.

Exogenous Hormones and ACTH Suppression

Both therapeutic and over-the-counter hormone preparations alter ACTH. This section covers the most common exposures seen in a telehealth hormone-therapy practice.

Glucocorticoids: Suppression at Any Route

Any exogenous glucocorticoid suppresses ACTH via negative feedback on the pituitary and hypothalamus. Potency and route determine the degree. Oral prednisone 5 mg/day for more than three weeks can suppress morning ACTH to <5 pg/mL in a significant proportion of patients [11]. Even inhaled fluticasone propionate at doses above 500 mcg/day has been associated with measurable HPA suppression in pediatric and adult studies, a fact not always appreciated by prescribing providers.

Topical potent corticosteroids (e.g., clobetasol propionate 0.05%) applied to large surface areas can suppress the HPA axis. Providers should document all steroid exposures, including nasal sprays and joint injections, before ordering ACTH.

Estrogen Therapy and CBG

Oral estrogen preparations (oral estradiol, conjugated equine estrogen) increase hepatic CBG synthesis, raising total cortisol by 30 to 50% without changing free cortisol or ACTH. This creates a dissociation: total cortisol looks high, ACTH looks normal, and free cortisol is actually the physiologically relevant analyte. Transdermal estradiol (patches, gels) does not significantly increase CBG and therefore does not create this artifact [12].

Women on oral estrogen who are being evaluated for adrenal insufficiency should have free or salivary cortisol measured rather than (or in addition to) total serum cortisol.

Testosterone and DHEA

As noted above, physiological testosterone replacement generally keeps ACTH in the lower-to-mid reference range. Supraphysiological androgen exposure (anabolic steroid use) may suppress ACTH by approximately 15 to 25% via androgen-receptor-mediated effects on hypothalamic CRH neurons, though the evidence base here is smaller and comes mainly from animal models and case series rather than randomized trials.

Oral DHEA supplementation at 25 to 50 mg/day does not meaningfully alter basal ACTH in most clinical studies, though one randomized trial in women with adrenal insufficiency (N=39) found no change in ACTH after 12 weeks of DHEA 50 mg/day despite improvements in self-reported well-being [13].

Primary vs. Secondary Adrenal Insufficiency: Using ACTH to Locate the Lesion

The diagnostic value of ACTH lies in pairing it with simultaneous cortisol. The combination creates a physiological coordinate that points to the level of pathology.

The ACTH-Cortisol Matrix

| ACTH | Cortisol | Interpretation | |---|---|---| | High (>63 pg/mL) | Low (<3 mcg/dL) | Primary adrenal insufficiency (Addison's disease) | | Low (<7.2 pg/mL) | Low (<10 mcg/dL) | Secondary (pituitary) or tertiary (hypothalamic) AI | | High (>63 pg/mL) | High (>20 mcg/dL) | Possible Cushing's disease, ectopic ACTH, or normal stress response | | Normal (10 to 46 pg/mL) | Low to borderline | Consider partial adrenal insufficiency; proceed to cosyntropin stimulation | | Normal | Normal | Normal HPA axis, or early/mild dysfunction requiring dynamic testing |

Cosyntropin Stimulation Testing

When basal ACTH and cortisol leave the diagnosis uncertain, a standard 250 mcg intravenous cosyntropin stimulation test provides additional information. A peak cortisol response <18 mcg/dL at 30 or 60 minutes is the widely cited cutoff for adrenal insufficiency, based on Endocrine Society guidelines [10]. However, the 18 mcg/dL threshold was derived from older radioimmunoassay platforms. Immunochemiluminescent assays (ICMA) used by most current labs read approximately 20% lower, meaning the functional threshold is closer to 14.5 to 16 mcg/dL on modern platforms. Confirming your lab's assay calibration before interpreting stimulation results is non-optional.

Longevity Medicine and Optimal ACTH: Moving Beyond "Not Diseased"

Standard reference ranges tell you whether a patient is within the distribution of a general population that includes many people with subclinical dysfunction. Longevity medicine asks a different question: what ACTH concentrations correlate with the best long-term metabolic and cognitive outcomes?

Evidence for a Functional Optimal Range

A 10-year observational analysis of 2,144 adults in the Baltimore Longitudinal Study of Aging found that participants with morning ACTH consistently in the 10 to 46 pg/mL range showed significantly lower all-cause inflammatory biomarker burden compared to those with ACTH persistently above 55 pg/mL, independent of cortisol levels [14]. Chronic ACTH elevation (even within the "normal" lab range) reflects sustained HPA drive that may accelerate hippocampal volume loss, impair insulin sensitivity, and suppress thyroid-stimulating hormone.

Interpreting Low-Normal ACTH

A morning ACTH of 8 to 12 pg/mL in a fatigued patient with low-normal cortisol, especially one on a proton-pump inhibitor, SSRI, or chronic low-dose corticosteroid, warrants further evaluation rather than reassurance. The cosyntropin stimulation test remains the standard next step per Endocrine Society guidance [10].

Sample Collection Checklist for Accurate ACTH Results

Correct collection technique prevents more errors than any algorithm for result interpretation.

• Draw time: 6 to 9 AM, fasting (water permitted)
• Tube: EDTA plasma (lavender top), pre-chilled on ice
• Transport: Place immediately on crushed ice after collection
• Processing: Centrifuge within 15 minutes; freeze plasma at minus 20 degrees Celsius if not running same day
• Patient prep: No vigorous exercise in the prior 24 hours; document all glucocorticoid exposures including topical and inhaled
• Women: Document cycle day; prefer days 2 to 7 for baseline assessment
• Document time of last dose of any estrogen, progestogen, testosterone, or corticosteroid